SIZE XSSIZE SMSIZE MDSIZE LG

September 2017 Journal Club Meeting

Originally presented September 21, 2017

Presenters & Articles

Stephen Farley, PharmD
PGY2 Oncology Resident
Roswell Park Cancer Institute, Buffalo, NY
Enasidenib in mutant—IDH2 relapsed or refractory acute myeloid leukemia

Kaitlyn Hughes, PharmD
PGY2 Pharmacy Resident in Oncology
Aurora Health Care Metro Inc., Milwaukee, WI
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small Cell Lung Cancer

Attendees

This free event is open to HOPA members and non-members.

Listen to this webinar.

https://hopa.adobeconnect.com/pz8t12f9fik7/

Questions about the HOPA Journal Club can be directed to: Emma Clawson, Education Coordinator at This email address is being protected from spambots. You need JavaScript enabled to view it..

 

xs
sm
md
lg